JACC: Basic to Translational Science (Feb 2020)

Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System?∗

  • Subodh Verma, MD, PhD

Journal volume & issue
Vol. 5, no. 2
pp. 180 – 182

Abstract

Read online

No abstracts available.

Keywords